Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes.
about
Role of oxidative stress in pathogenesis of metabolic syndromeThe Effect of Glucose Fluctuation on Apoptosis and Function of INS-1 Pancreatic Beta CellsQuantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.A single consumption of curry improved postprandial endothelial function in healthy male subjects: a randomized, controlled crossover trial.Rapid quantitative analysis of 8-iso-prostaglandin-F(2alpha) using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method.A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress.F2-isoprostanes as an indicator and risk factor for coronary heart disease.A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsImpact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.An efficient sample preparation method for high-throughput analysis of 15(S)-8-iso-PGF2α in plasma and urine by enzyme immunoassay.Impact of ramadan intermittent fasting on oxidative stress measured by urinary 15-f(2t)-isoprostaneHyperglycemia Differentially Affects Maternal and Fetal DNA Integrity and DNA Damage Response.Mechanisms of atherothrombosis in chronic obstructive pulmonary disease.Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease.Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stressStrategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.
P2860
Q33361889-45728B3B-D88F-4330-AEBD-B68B9EFB396EQ33598321-B2AFC93A-0513-436D-B39E-5A8A326C355DQ33783345-3DAC2F27-1802-4A44-80BE-6018522D5F52Q33848196-101FE2B1-2E25-489A-9991-BEF837C1EEF0Q34018593-9F7C7CE5-51FF-4512-8D9D-3B8393770045Q34595337-C7A392CF-4634-45B2-B75A-B1ABB9560DCBQ34684200-FBE10A8D-DF51-461D-B63A-A60BA81C080FQ35897007-910F4C1B-9ABA-4830-A050-F6B642A3A42EQ36024430-6C0B5505-1CE7-4A29-9EB2-93845AEA7219Q36318196-9A0F6298-021E-4498-A9C3-90E90E72A2DAQ36361108-D826A523-F79D-4852-80BB-D869F72F8596Q36727120-1A0EA714-0A0A-4C0D-90A4-007DA7A5678AQ36859410-9AC127AA-FC62-443D-AE52-1F785140AC95Q37218342-DD2C4772-3515-453A-A11B-1FA1A2D4DF99Q37307074-58EFC36B-554F-4913-8171-B45120D2E242Q55279804-3B49DDD3-347D-45F8-82DB-17391978A296
P2860
Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Divergence between LDL oxidative susceptibility and urinary F
@nl
Divergence between LDL oxidati ...... ive stress in type 2 diabetes.
@en
type
label
Divergence between LDL oxidative susceptibility and urinary F
@nl
Divergence between LDL oxidati ...... ive stress in type 2 diabetes.
@en
prefLabel
Divergence between LDL oxidative susceptibility and urinary F
@nl
Divergence between LDL oxidati ...... ive stress in type 2 diabetes.
@en
P2093
P1433
P1476
Divergence between LDL oxidati ...... tive stress in type 2 diabetes
@en
P2093
P304
P407
P577
2001-11-01T00:00:00Z